Device sales up 8% at Synthelabo
This article was originally published in Clinica
Executive Summary
Synthelabo's medical device sales rose 8.3% on a comparable basis in the first half of 1995 to Fr 355 million ($70 million) compared with the same period last year. This includes worldwide sales of Fr 261 million for the company's pacemaker subsidiary, Ela Medical, and Fr 94 million for its surgical catheter division, Porges.